Some evidence suggests the wish to hasten death is related to poor health-related quality of life. Deficits in perceived dignity and self-efficacy are risk factors for wish to hasten death that also impact health-related quality of life.
Aim:
To compare perceived health-related quality of life, dignity and self-efficacy in patients with advanced cancer who either do (case group) or do not (control group) express a wish to hasten death. Cases and controls were matched on sociodemographic and functional characteristics.
Design:
A comparative cross-sectional study.
Participants:
A total of 153 adult patients with advanced cancer were assessed for wish to hasten death using the Desire for Death Rating Scale. Scores ⩾1 indicate some degree of wish to hasten death (case group, n = 51), and score = 0 implies no wish to hasten death (control group, n = 102). Assessments included health-related quality of life using the European Organization for Research and Treatment of Cancer Quality-of-Life Core 15-Item Palliative Questionnaire, perceived loss of dignity using the Patient Dignity Inventory and self-efficacy using the General Self-Efficacy Scale.
Results:
Patients with a wish to hasten death had worse emotional functioning (p < 0.001), greater perceived loss of dignity (p < 0.001) and lower self-efficacy (p = 0.001). There was no difference in most physical symptoms. Perceived overall health-related quality of life was significantly worse for those with a clinically relevant wish to hasten death (p = 0.023) and marginally worse for the case group than the control group (p = 0.052).
Conclusion:
Patients with wish to hasten death showed lower perceived dignity, self-efficacy and emotional quality of life than patients without wish to hasten death without necessarily perceiving worse physical symptoms.
BalaguerAMonforte-RoyoCPorta-SalesJ, et al. An international consensus definition of the wish to hasten death and its related factors. PLoS ONE2016; 11(1): e0146184.
2.
Bellido-PérezMMonforte-RoyoCTomás-SábadoJ, et al. Assessment of the wish to hasten death in patients with advanced disease: a systematic review of measurement instruments. Palliat Med2017; 31(6): 510–525.
3.
HudsonPLKristjansonLJAshbyM, et al. Desire for hastened death in patients with advanced disease and the evidence base of clinical guidelines: a systematic review. Palliat Med2006; 20(7): 693–701.
4.
Monforte-RoyoCVillavicencio-ChávezCTomás-SábadoJ, et al. What lies behind the wish to hasten death? A systematic review and meta-ethnography from the perspective of patients. PLoS ONE2012; 7(5): e37117.
5.
OhnsorgeKGudatHRehmann-SutterC.What a wish to die can mean: reasons, meanings and functions of wishes to die, reported from 30 qualitative case studies of terminally ill cancer patients in palliative care. BMC Palliat Care2014; 13: 38.
6.
CassellEJ.The nature of suffering and the goals of medicine. N Engl J Med1982; 306(11): 639–645.
7.
WilsonKGChochinovHMMcPhersonCJ, et al. Suffering with advanced cancer. J Clin Oncol2007; 25: 1691–1697.
8.
BestMAldridgeLButowP, et al. Conceptual analysis of suffering in cancer: a systematic review. Psycho-Oncology2015; 24(9): 977–986.
9.
BullingerM.Quality of life – definition, conceptualization and implications: a methodologist view. Theor Surg1991; 6: 143–148.
10.
CellaDF.Quality of life: concepts and definition. J Pain Symptom Manage1994; 9(3): 186–192.
11.
TestaMASimonsonDC.Assessment of quality of life outcomes. N Engl J Med1996; 334: 835–840.
12.
RosenfeldBBreitbartWGaliettaM, et al. The schedule of attitudes toward hastened death: measuring desire for death in terminally ill cancer patients. Cancer2000; 88(12): 2868–2875.
13.
RobinsonSKissaneDWBrookerJ, et al. The relationship between poor quality of life and desire to hasten death: a multiple mediation model examining the contributions of depression, demoralization, loss of control, and low self-worth. J Pain Symptom Manage2017; 53(2): 243–249.
14.
ChochinovHMHassardTMcClementS, et al. The patient dignity inventory: a novel way of measuring dignity-related distress in palliative care. J Pain Symptom Manage2008; 36(6): 559–571.
15.
Monforte-RoyoCCrespoIRodríguez-PratA, et al. The role of perceived dignity and control in the wish to hasten death among advanced cancer patients: a mediation model. Psycho-Oncology2018; 27(12): 2840–2846.
16.
MilbergAFriedrichsenMJakobssonM, et al. Patients’ sense of security during palliative care-what are the influencing factors. J Pain Symptom Manage2014; 48(1): 45–55.
17.
BadanaANSMarinoVRTemplemanME, et al. Understanding the roles of patient symptoms and subjective appraisals in well-being among breast cancer patients. Support Care Cancer2019; 27(11): 4245–4252.
18.
JohansenSHølenJCKaasaS, et al. Attitudes towards, and wishes for, euthanasia in advanced cancer patients at a palliative medicine unit. Palliat Med2005; 19(6): 454–460.
19.
FerrellBRTemelJSTeminS, et al. Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol2017; 35(1): 96–112.
20.
Bellido-PérezMCrespoIWilsonKG, et al. Assessment of the wish to hasten death in patients with advanced cancer: a comparison of 2 different approaches. Psycho-Oncology2018; 27(6): 1538–1544.
21.
WilsonKGGrahamIDViolaRA, et al. Structured interview assessment of symptoms and concerns in palliative care. Can J Psychiatry2004; 49(6): 350–358.
22.
MahoneyFIBarthelDW.Functional evaluation: the Barthel Index. Md State Med J1965; 14: 61–65.
23.
YatesJWChalmerBMcKegneyFP.Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer1980; 45(8): 2220–2224.
24.
EchteldMADeliensLOntwuteaka-PhilipsenB, et al. EORTC QLQ-C15-PAL: the new standard in the assessment of health-related quality of life in advanced cancer?Palliat Med2006; 20(1): 1–2.
25.
GroenvoldMPetersenMAAaronsonNK, et al. The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer2006; 42(1): 55–64.
26.
RullánMCarvajalANunez-CordobaJM, et al. Spanish version of the patient dignity inventory: translation and validation in patients with advanced cancer. J Pain Symptom Manage2015; 50(6): 874–881.e1.
27.
BanduraA.Self-efficacy mechanism in human agency. Am Psychol1982; 37(2): 122–147.
28.
BaesslerJSchwarzerR.Evaluación de la autoeficacia: adaptación española de la escala de Autoeficacia General. Ansiedad Estrés1996; 2: 1–8.
29.
ByockIRMerrimanMP.Measuring quality of life for patients with terminal illness: the Missoula-VITAS quality of life index. Palliat Med1998; 12: 231–244.
30.
AbrahamAKutnerJSBeatyB.Suffering at the end of life in the setting of low physical symptom distress. J Palliat Med2006; 9(3): 658–665.
31.
BretscherMRummansTSloanJ, et al. Quality of life in hospice patients: a pilot study. Psychosomatics1999; 40(4): 309–313.
32.
KaasaSLogeJH.Quality of life in palliative care: principles and practice. Palliat Med2003; 17(1): 11–20.
33.
ChochinovHMTatarynDClinchJJ, et al. Will to live in the terminally ill. Lancet1999; 354: 816–819.
34.
RummansTABostwickJMClarkMM, et al. Maintaining quality of life at the end of life. Mayo Clin Proc2000; 75(12): 1305–1310.
35.
ChochinovHMWilsonKGEnnsM, et al. Depression, hopelessness and suicidal ideation in the terminally ill. Psychosomatics1998; 39(4): 366–370.
36.
VehlingSKissaneDWLoC, et al. The association of demoralization with mental disorders and suicidal ideation in patients with cancer. Cancer2017; 123(17): 3394–3401.
37.
FangCKChangMCChenPJ, et al. A correlational study of suicidal ideation with psychological distress, depression, and demoralization in patients with cancer. Support Care Cancer2014; 22(12): 3165–3174.
38.
VehlingSMehnertA.Symptom burden, loss of dignity, and demoralization in patients with cancer: a mediation model. Psycho-Oncology2014; 23(3): 283–290.
39.
LeMayKWilsonKG.Treatment of existential distress in life threatening illness: a review of manualized interventions. Clin Psychol Rev2008; 28(3): 472–493.
40.
ChochinovHMKristjansonLJBreitbartW, et al. Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial. Lancet Oncol2011; 12(8): 753–762.
41.
BreitbartWRosenfeldBPessinH, et al. Meaning-centered group psychotherapy: an effective intervention for improving psychological well-being in patients with advanced cancer. J Clin Oncol2015; 33(7): 749–754.
42.
RodinGLoCRydallA, et al. Managing cancer and living meaningfully (CALM): a randomized controlled trial of a psychological intervention for patients with advanced cancer. J Clin Oncol2018; 36(23): 2422–2432.
43.
BreitbartWPessinHRosenfeldB, et al. Individual meaning-centered psychotherapy for the treatment of psychological and existential distress: a randomized controlled trial in patients with advanced cancer. Cancer2018; 124(15): 3231–3239.
44.
HaggerMSKochSChatzisarantisNLD, et al. The common sense model of self-regulation: meta-analysis and test of a process model. Psychol Bull2017; 143(11): 1117–1154.
45.
HallSDaviesJMGaoW, et al. Patterns of dignity-related distress at the end of life: a cross-sectional study of patients with advanced cancer and care home residents. Palliat Med2014; 28(9): 1118–1127.
46.
MorenoPIRamirezAGSan Miguel-MajorsSL, et al. Satisfaction with cancer care, self-efficacy, and health-related quality of life in Latino cancer survivors. Cancer2018; 124(8): 1770–1779.
47.
BradyMJPetermanAHFitchettG, et al. A case for including spirituality in quality of life measurement in oncology. Psycho-Oncology1999; 8(5): 417–428.
48.
WangYCLinCC.Spiritual well-being may reduce the negative impacts of cancer symptoms on the quality of life and the desire for hastened death in terminally ill cancer patients. Cancer Nurs2016; 39(4): E43–E50.
49.
ZhangBNilssonMEPrigersonHG.Factors important to patients’ quality of life at the end of life. Arch Intern Med2012; 172(15): 1133–1142.
